Works matching IS 10233830 AND DT 2019 AND VI 68 AND IP 4


Results: 8
    1
    2
    3
    4
    5
    6

    Toreforant, an orally active histamine H<sub>4</sub>-receptor antagonist, in patients with active rheumatoid arthritis despite methotrexate: mechanism of action results from a phase 2, multicenter, randomized, double-blind, placebo-controlled synovial biopsy study

    Published in:
    Inflammation Research, 2019, v. 68, n. 4, p. 261, doi. 10.1007/s00011-019-01218-y
    By:
    • Boyle, David L.;
    • DePrimo, Samuel E.;
    • Calderon, Cesar;
    • Chen, Dion;
    • Dunford, Paul J.;
    • Barchuk, William;
    • Firestein, Gary S.;
    • Thurmond, Robin L.
    Publication type:
    Article
    7
    8